Predictive Molecular and Integrative Pathology in Thyroid Carcinoma
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 238
Special Issue Editors
Interests: thyroid carcinoma
Special Issues, Collections and Topics in MDPI journals
Interests: renal pathology; glomerulonephritis; autoimmunity; molecular pathology; digital pathology; thyroid carcinoma; proteomics; MALDI imaging
Special Issue Information
Dear Colleagues,
The detection of a thyroid nodule is a frequent instance in medicine, and its characterization to detect early-stage thyroid cancer still has as gold standard cytological assessment through fine-needle aspiration (FNA). However, 15–25% of these cases still end up as indeterminate for malignancy, requiring diagnostic thyroidectomies. To reduce this gap and improve precision medicine in this field, additional imaging approaches and molecular pathology tools have been proposed to restrict the percentage of avoidable thyroidectomies.
This Special Issue of Cells on “Predictive molecular and integrative pathology in thyroid carcinoma” solicits original research articles and reviews highlighting exciting new findings in the area of diagnostic, prognostic, and predictive biomarkers in thyroid cancer. We especially welcome review articles (either systematic or discursive), original translational research studies, and short communications of preliminary but significant experimental results. Each submitted manuscript will go through a rigorous peer-review process. Submitted manuscripts must not have been published previously nor be under consideration for publication in other journals.
Prof. Dr. Fabio Pagni
Dr. Vincenzo L'Imperio
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thyroid cancer
- molecular pathology
- integrative pathology
- digital pathology
- translational research
- precision medicine
- targeted therapy
- MALDI imaging
